Industry should improve the standards on application of risk management tools in light of the cases of nitrosamine impurities.
Niamh Panesar
Advertisement
Niamh Panesar is CMC senior manager at Kinapse Ltd, UK.
Articles by Niamh Panesar
Advertisement
Latest Updated Articles
Nitrosamine Impurities in Medicinal ProductsDecember 2nd 2020
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
Is Compliant AI in Pharma Even Possible? The Search for an Honest Answer
5